Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

EPIDEMIOLOGY OF HEPATITIS E VIRUS INFECTION IN A COHORT OF 4,023 IMMUNOCOMPROMISED PATIENTS

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prevalence of anti-Hepatitis E virus immunoglobulin G in HIV-infected individuals over three decades

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hepatitis E virus epidemiology among HIV-infected women in an urban area in Tanzania

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Incidence of HACEK bacteraemia in Denmark: A 6-year population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. High incidence of candidaemia in a nationwide cohort: underlying diseases, risk factors and mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Quantification of sexual HIV transmission risk in Africa

    Research output: Contribution to journalEditorialResearchpeer-review

  1. Behandling af tymom og thymuskarcinom

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: The prevalence of active, chronic and former hepatitis E virus (HEV) infections in a cohort of immunocompromised patients was investigated, the association with transfusion transmitted (TT) HEV was evaluated, and the HEV seroprevalence was compared with healthy blood donors.

STUDY DESIGN AND METHODS: Serum samples from 4,023 immunocompromised patients at Rigshospitalet, Denmark were retrospectively tested for HEV RNA and anti-HEV IgG. HEV RNA-positive patients were followed up by HEV testing, clinical symptoms and transfusion history. Factors associated with anti-HEV were explored using a multivariable logistic regression analysis. Samples from 1,226 blood donors were retrospectively tested for anti-HEV IgG.

RESULTS: HEV RNA was detected in 6 patients (0.15%) with no indications of chronic HEV infections. HEV RNA prevalence rates among recipients of allogeneic haematopoietic stem cell transplantation (allo-HSCT) and solid organ transplantation (SOT) were 0.58% and 0.21%, respectively. TT-infections were refuted, and transfusion history was not associated with anti-HEV positivity. HEV seroprevalence difference between patients (22.0%) and blood donors (10.9%) waned when adjusting for age and sex (odds ratio 1.20; CI 0.97-1.48).

CONCLUSION: HEV viremia among allo-HSCT and SOT recipients suggests that clinicians should be aware of this diagnosis. No association of blood transfusion with anti-HEV positivity support that food borne transmission is the main transmission route of HEV common to both patients and blood donors.

Original languageEnglish
JournalInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN1201-9712
DOIs
Publication statusE-pub ahead of print - 19 Nov 2019

ID: 58451913